Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, securing $3.5 million.

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...

Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity ...

Under mild Markov assumptions, sufficient conditions for strict minimax optimality of sequential tests for multiple hypotheses under distributional uncertainty are derived. First, the design of ...

Module technologies tipped to enter the mainstream and the suitability of current testing methods were scrutinised at PV ModuleTech 2017. PV Tech caught up with Mark Ma, global marketing manager, ...